Literature DB >> 8315180

Measured versus estimated creatinine clearance in a high-functioning elderly sample: MacArthur Foundation Study of Successful Aging.

L C Malmrose1, S L Gray, C F Pieper, D G Blazer, J W Rowe, T E Seeman, M S Albert.   

Abstract

OBJECTIVE: To assess the validity of several equations for estimating creatinine clearance in a large sample of high-functioning, community-dwelling elderly.
DESIGN: Serum and 12-hour urine samples were collected and assayed for creatinine using the Jaffe total chromagen method. Fifteen clearance-estimating equations were evaluated for bias, accuracy, correlation with measured clearance values, and frequency of erroneous placement into renal function categories. Stepwise regression modeling and reliability testing were performed on a split sample to construct and assess a novel creatinine-clearance-estimating equation.
SETTING: New Haven, Connecticut, East Boston, Massachusetts, and a five-county region in and around Durham, North Carolina. PARTICIPANTS: A subsample of community-dwelling men and women (age range 70-79 years) from the Established Populations for Epidemiological Studies of the Elderly was screened for physical and cognitive functioning and placed into high-, medium-, and low-functioning groups (n = 1354). High-functioning respondents who provided blood and complete urine samples (n = 762) were included in the present study.
RESULTS: In general, estimated creatinine clearance was more closely correlated to measured values in males than in females. Most equations underestimated creatinine clearance, with average bias ranging from -33.1 mL/min to +19.6 mL/min. Predictive accuracy ranged from 18.2 mL/min to 38.0 mL/min. Equations were variable in their erroneous placement of individuals into renal function categories. Regression modeling yielded an equation which contained novel components but failed to provide better estimates of creatinine clearance than those already available.
CONCLUSIONS: The equations evaluated here provide unacceptable predictions of creatinine clearance in normally aging individuals. We advocate the use of serum drug concentration measurements when available and encourage investigation into timed urine collections of short duration as alternatives to clearance-estimating equations in the elderly.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8315180     DOI: 10.1111/j.1532-5415.1993.tb07459.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  7 in total

Review 1.  Checkpoint inhibition and melanoma: Considerations in treating the older adult.

Authors:  Claire F Friedman; Jedd D Wolchok
Journal:  J Geriatr Oncol       Date:  2017-05-11       Impact factor: 3.599

2.  Calcium metabolism in the frail elderly.

Authors:  Jane Zochling; Jian Sheng Chen; Markus Seibel; Jennifer Schwarz; Ian D Cameron; Robert G Cumming; Lyn March; Philip N Sambrook
Journal:  Clin Rheumatol       Date:  2005-08-05       Impact factor: 2.980

Review 3.  Choice and use of newer anticonvulsant drugs in older patients.

Authors:  L J Willmore
Journal:  Drugs Aging       Date:  2000-12       Impact factor: 3.923

Review 4.  Cardiovascular drug therapy in the elderly: theoretical and practical considerations.

Authors:  Bradley R Williams; Jiwon Kim
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

5.  Correlation of Measured and Estimated Creatinine Clearance in Hospitalized Elderly Patients: A Retrospective Cohort Study.

Authors:  Rachel I Lavelle; Austin R Brown; Anthony Gerlach
Journal:  Hosp Pharm       Date:  2020-05-17

6.  Predictors of normal and successful aging among urban-dwelling elderly Brazilians.

Authors:  Márcia Lorena Chaves; Ana Luiza Camozzato; Cláudio Laks Eizirik; Jeffrey Kaye
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-07-15       Impact factor: 4.077

Review 7.  Principles and clinical application of assessing alterations in renal elimination pathways.

Authors:  Susan E Tett; Carl M J Kirkpatrick; Annette S Gross; Andrew J McLachlan
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.